Mike Radossich has been named president of the Solvay Group’s Novecare global business unit. He will succeed Emmanuel Butstraen, who will leave to pursue opportunities outside of the Group. Mike will lead the business unit, which makes specialty surfactants and formulations serving customers in agriculture, coatings, home and personal care, industrial and oil and gas markets. Mike will be based in Novecare’s headquarters in Princeton, New Jersey.

Mike Radossich, President of Technology Solutions GBU, USA

Mike came to Solvay from Cytec Industries when the Group acquired its businesses in 2016. He has more than 25 years of experience managing global and regional teams in commercial, operational and technical functions. He most recently headed up the Group’s Technology Solutions global business unit. Mike earned his undergraduate degree in Chemical Engineering from Villanova University and an MBA from Fairleigh Dickinson University.

FOLLOW US ON TWITTER @SOLVAYGROUP

About Solvay Novecare

Solvay Novecare is a worldwide leader in specialty surfactants and a major player in polymers, amines, guar, and phosphorus derivatives. It engineers products that modify fluid behavior and deliver cleansing, dispersal, gelling, moisturizing, penetrating, softening or texturizing properties. Novecare has a worldwide network of 37 manufacturing sites and nine R&I centers.

About Solvay

Solvay is an advanced materials and specialty chemicals company, committed to developing chemistry that addresses key societal challenges. Solvay innovates and partners with customers worldwide in many diverse end markets. Its products are used in planes, cars, batteries, smart and medical devices, as well as in mineral and oil and gas extraction, enhancing efficiency and sustainability. Its lightweighting materials promote cleaner mobility, its formulations optimize the use of resources and its performance chemicals improve air and water quality. Solvay is headquartered in Brussels with around 26,800 employees in 61 countries. Net sales were €10.1 billion in 2017, with 90% from activities where Solvay ranks among the world’s top 3 leaders, resulting in an EBITDA margin of 22%. Solvay SA (SOLB.BE) is listed on Euronext Brussels and Paris (Bloomberg: SOLB.BB - Reuters: SOLB.BR) and in the United States its shares (SOLVY) are traded through a level-1 ADR program. Financial figures take into account the announced divestment of Polyamides.

Contact us